Videos
Ruben Mesa, M.D., director of the UT Health San Antonio Cancer Center, discusses complementary therapy for patients with myeloproliferative neoplasms (MPNs).
Joshua Bauml, M.D., assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the potential of therapeutic vaccine in patients who have head and neck cancer.
Advertisement
Advertisement
Trending on CURE
1
Pancreatic Cancer and Enzyme Pills: Why They Matter at Every Meal
2
Rural Lung Cancer: Only 36% of Medicare Patients Had Gene Testing
3
FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer
4
Nearly Half of Cancer Survivors Report Recent Alcohol Use
5